Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2016

01-09-2016 | Case Report

Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature

Authors: Eirini Pectasides, Rebecca Miksad, Sergey Pyatibrat, Amogh Srivastava, Andrea Bullock

Published in: Digestive Diseases and Sciences | Issue 9/2016

Login to get access

Abstract

Spontaneous regression of hepatocellular carcinoma (HCC) is a rare event. Here we present a case of spontaneous regression of metastatic HCC. A 53-year-old man with hepatitis C and alcoholic cirrhosis was found to have a large liver mass consistent with HCC based on its radiographic features. Imaging also revealed left portal and hepatic vein thrombosis, as well as multiple lung nodules concerning for metastases. Approximately 2 months after the initial diagnosis, both the primary liver lesion and the lung metastases decreased in size and eventually resolved without any intervention. Thereafter, the left hepatic vein thrombus progressed into the inferior vena cava and the right atrium, and the patient died due to right heart failure. In this case report and literature review, we discuss the potential mechanisms for and review the literature on spontaneous regression of metastatic HCC.
Literature
1.
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
2.
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology. 2000;31:840–845.
3.
4.
5.
Cole WH. Spontaneous regression of cancer and the importance of finding its cause. Natl Cancer Inst Monogr. 1976;44:5–9.PubMed
6.
Bruix J, Sherman M, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011;1020–1022.
7.
Okuma K, Yamashita H, Niibe Y, Hayakawa K, Nakagawa K. Abscopal effect of radiation on lung metastases of hepatocellular carcinoma: a case report. J Med Case Rep. 2011;5:111.CrossRefPubMedPubMedCentral
8.
Nam SW, Han J-Y, Kim JI, et al. Spontaneous regression of a large hepatocellular carcinoma with skull metastasis. J Gastroenterol Hepatol. 2005;20:488–492.CrossRefPubMed
9.
10.
Abiru S, Kato Y, Hamasaki K, Nakao K, Nakata K, Eguchi K. Spontaneous regression of hepatocellular carcinoma associated with elevated levels of interleukin 18. Am J Gastroenterol. 2002;97:774–775.CrossRefPubMed
11.
Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88–91.CrossRefPubMed
12.
Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res. 2000;60:4838–4844.PubMed
13.
Kumar T, Patel N, Talwar A. Spontaneous regression of thoracic malignancies. Respir Med. 2010;104:1543–1550.CrossRefPubMed
14.
Heianna J, Miyauchi T, Suzuki T, Ishida H, Hashimoto M, Watarai J. Spontaneous regression of multiple lung metastases following regression of hepatocellular carcinoma after transcatheter arterial embolization. A case report. Hepatogastroenterology. 2007;54:1560–1562.PubMed
15.
Lam KC, Ho JC, Yeung RT. Spontaneous regression of hepatocellular carcinoma: a case study. Cancer. 1982;50:332–336.CrossRefPubMed
16.
Okano A, Ohana M, Kusumi F, Nabeshima M. Spontaneous regression of hepatocellular carcinoma due to disruption of the feeding artery. Case Rep Oncol. 2013;6:180–185.CrossRefPubMedPubMedCentral
17.
Tomino T, Yamashita Y-I, Iguchi T, et al. Spontaneous massive necrosis of hepatocellular carcinoma with narrowing and occlusion of the arteries and portal veins. Case Rep Gastroenterol. 2014;8:148–155.CrossRefPubMedPubMedCentral
18.
Imaoka S, Sasaki Y, Masutani S, et al. Necrosis of hepatocellular carcinoma caused by spontaneously arising arterial thrombus. Hepatogastroenterology. 1994;41:359–362.PubMed
19.
Iiai T, Sato Y, Nabatame N, Yamamoto S, Makino S, Hatakeyama K. Spontaneous complete regression of hepatocellular carcinoma with portal vein tumor thrombus. Hepatogastroenterology. 2003;50:1628–1630.PubMed
20.
Alqutub A, Peck D, Marotta P. Spontaneous regression of a large hepatocellular carcinoma: case report. Ger Med Sci. 2011;9:Doc07.
21.
Sato Y, Fujiwara K, Nakagawa S, et al. A case of spontaneous regression of hepatocellular carcinoma with bone metastasis. Cancer. 1985;56:667–671.CrossRefPubMed
22.
Harimoto N, Shirabe K, Kajiyama K, et al. Spontaneous regression of multiple pulmonary recurrences of hepatocellular carcinoma after hepatectomy: report of a case. Surg Today. 2012;42:475–478.CrossRefPubMed
23.
Storey RE, Huerta AL, Khan A, Laber DA. Spontaneous complete regression of hepatocellular carcinoma. Med Oncol. 2011;28:948–950.CrossRefPubMed
24.
Kojima H, Tanigawa N, Kariya S, et al. A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases. Radiat Med. 2006;24:139–142.CrossRefPubMed
25.
Kondo S, Okusaka T, Ueno H, Ikeda M, Morizane C. Spontaneous regression of hepatocellular carcinoma. Int J Clin Oncol. 2006;11:407–411.CrossRefPubMed
26.
Han S-B, Lee CW, Kang JS, et al. Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion. Int Immunopharmacol. 2006;6:697–702.CrossRefPubMed
27.
Yang B-K, Hwang S-L, Yun I-J, et al. Antitumor effects and immunomodulating activities of Phellinus linteus extract in a CT-26 cell-injected colon cancer mouse model. Mycobiology. 2009;37:128–132.CrossRefPubMedPubMedCentral
28.
Sliva D, Jedinak A, Kawasaki J, Harvey K, Slivova V. Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer. 2008;98:1348–1356.CrossRefPubMedPubMedCentral
29.
McCaughan GW, Bilous MJ, Gallagher ND. Long-term survival with tumor regression in androgen-induced liver tumors. Cancer. 1985;56:2622–2626.CrossRefPubMed
30.
Nouso K, Uematsu S, Shiraga K, et al. Regression of hepatocellular carcinoma during vitamin K administration. World J Gastroenterol. 2005;11:6722–6724.CrossRefPubMedPubMedCentral
31.
Lim DH, Park KW, Lee SI. Spontaneous complete regression of multiple metastases of hepatocellular carcinoma: a case report. Oncol Lett. 2014;7:1225–1228.PubMedPubMedCentral
32.
Ikeda M, Okada S, Ueno H, Okusaka T, Kuriyama H. Spontaneous regression of hepatocellular carcinoma with multiple lung metastases: a case report. Jpn J Clin Oncol. 2001;31:454–458.CrossRefPubMed
33.
Toyoda H, Sugimura S, Fukuda K, Mabuchi T. Hepatocellular carcinoma with spontaneous regression of multiple lung metastases. Pathol Int. 1999;49:893–897.CrossRefPubMed
34.
Jeon S-W, Lee M-K, Lee Y-D, et al. Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions. Korean J Int Med. 2005;20:268–273.CrossRef
35.
36.
Saito T, Naito M, Matsumura Y, et al. Spontaneous regression of a large hepatocellular carcinoma with multiple lung metastases. Gut Liver. 2014;8:569–574.CrossRefPubMedPubMedCentral
37.
Kato H, Nakamura M, Muramatsu M, Orito E, Ueda R, Mizokami M. Spontaneous regression of hepatocellular carcinoma: two case reports and a literature review. Hepatol Res. 2004;29:180–190.CrossRefPubMed
38.
Arora N, Madhusudhana S. Spontaneous regression of hepatocellular cancer: case report and review of literature. Gastrointest Cancer Res. 2011;4:141–143.PubMedPubMedCentral
Metadata
Title
Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature
Authors
Eirini Pectasides
Rebecca Miksad
Sergey Pyatibrat
Amogh Srivastava
Andrea Bullock
Publication date
01-09-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4141-2

Other articles of this Issue 9/2016

Digestive Diseases and Sciences 9/2016 Go to the issue

Editorial

Management of Sphincter of Oddi Dysfunction: Teaching an Old SOD New Tricks?

Original Article

Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn’s Disease Phenotypes

Original Article

Most Premature Surveillance Colonoscopy Is Not Attributable to Bowel Preparation or New Clinical Indications

Original Article

Clinical Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma of the Esophagogastric Junction

Case Report

Feasibility of Cold Snare Polypectomy for Multiple Duodenal Adenomas in Patients with Familial Adenomatous Polyposis: A Pilot Study

Original Article

Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits